Otsuka Pharmaceutical Development & Commercialization, Inc.
2
Astellas Pharma Global Development, Inc.
1
H. Lundbeck A/S
1
Janssen Research & Development, LLC
1
Karuna Therapeutics
1
SyneuRx International (Taiwan) Corp
1
Clinical Trials at Michigan Clinical Research Institute PC
During the past decade, Michigan Clinical Research Institute PC conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on
average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7%
of trials that started reached the finish line.
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
2018-12-04
2023-12-29
Active, not recruiting
128
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Michigan Clinical Research Institute PC" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials
sponsored, "Emalex Biosciences Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "LivaNova"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 11 trials in total.
Clinical Trials Conditions at Michigan Clinical Research Institute PC
According to Clinical.Site data, the most researched conditions in "Michigan Clinical Research Institute PC" are
"Schizophrenia" (6 trials), "Treatment Resistant Depression" (2 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials), "Depressive Disorder, Major" (1 trials) and "Obsessive Compulsive Disorder" (1 trials). Many other conditions were trialed in "Michigan Clinical Research Institute PC" in a lesser frequency.
Clinical Trials Intervention Types at Michigan Clinical Research Institute PC
Most popular intervention types in "Michigan Clinical Research Institute PC" are "Drug" (15 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "BI 409306" (2 trials), "Ecopipam" (2 trials), "ASP4345" (1 trials) and "AVP-786" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Michigan Clinical Research Institute PC
The vast majority of trials in "Michigan Clinical Research Institute PC" are
18 trials for "All" genders.
Clinical Trials Status at Michigan Clinical Research Institute PC
Currently, there are NaN active trials in "Michigan Clinical Research Institute PC".
undefined are not yet recruiting,
6 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 5 completed trials in Michigan Clinical Research Institute PC,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Michigan Clinical Research Institute PC, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".